E-DRUG Archives (by thread)

  • [e-drug] Book: Managing Pharmaceuticals in International Health, reinhard huss
  • [e-drug] What is the pharmaceutical industry up to?, E-drug
  • [e-drug] Vioxx withdrawal (2), Peter R Mansfield
  • [e-drug] ICIUM 2004 recommendations and presentations online, E-drug
  • [e-drug] Is that it, then, for blockbuster drugs?, E-Drug
  • [e-drug] BBC Panorama examines antidepressants and UK Regulatory Authority, E-Drug
  • [e-drug] FIP launches International Network for Pharmacists on HIV/AIDS, Teresa Alves
  • [e-drug] Australian Prescriber October issue, Susan Reid
  • [e-drug] urgent clinical advice needed, Drug Information Center, Manipal Teaching Hospital, Pokhara
  • [e-drug] Workshop on TB Pharmaceutical Management: 29 October, Paris, Beith,Alix
  • [e-drug] The need for openness in drug regulation, E-drug
  • [e-drug] USAID Awards TB Alliance $8 Million Grant, E-Drug
  • [e-drug] donor required for second line TB drugs in Nepal, Drug Information Center, Manipal Teaching Hospital, Pokhara
  • [e-drug] fake artemisinins and ARVs in DR Congo (3), Sabine Kopp
  • [e-drug] Vioxx - another block buster goes bust, Ayyaz Kiani
  • [e-drug] The World Medicines Situation, E-drug
  • [e-drug] Alternatives for the patent system?, E-Drug
  • [e-drug] The Truth About the Drug Companies, E-Drug
  • [e-drug] The Truth About the Drug Companies (2), Dr Valeria Frighi
  • [e-drug] For a Balanced Debate, Let the Pharmaceutical Industry Speak, Kibumba George
  • [e-drug] Pharmaceutical Companies might not be making a lot, Kibumba George
  • [e-drug] Pharmaceutical Companies might not be making a lot (2), E-Drug
  • [e-drug] Corporate sponsorship of diabetes campaigns in developing countries, Patient View
  • [e-drug] Essential drugs for mental health, Kees de Joncheere
  • [e-drug] Financing drug research and development, Marcus Reidenberg
  • [e-drug] Financing drug research and development (2), Dr.L.Offerhaus
  • [e-drug] The Truth About the Drug Companies (4), E-drug
  • [e-drug] E-DRUG: The Truth About the Drug Companies (5), JPS Kohli
  • [e-drug] Alternatives for the patent system? (3), Parrish Richard
  • [e-drug] Let Pharmaceutical Companies Speak (2), Kibumba George
  • [e-drug] Avian influenza should be ruffling our feathers, E-Drug
  • [e-drug] bad bugs, no drugs, E-Drug
  • [e-drug] Access to Medicines and Intellectual Property Rights, Wilbert Bannenberg
  • [e-drug] Access to Medicines in Under-served Markets: overview, E-drug
  • [e-drug] ATM: willingness and ability to utilise TRIPS flexibilities, E-Drug
  • [e-drug] vacancy: IDA South Africa project manager, Mrs Marieke Dekker
  • [e-drug] Drug maker promotes generics for its own workers, Joana Ramos
  • [e-drug] WHO Essential Medicines List 2005: deadline 31 Oct, E-Drug
  • [e-drug] Strong medicine - Incentives for R&D on Neglected Diseases, E-Drug
  • [e-drug] Comments about PEPFAR (2), Libby Levison
  • [e-drug] a malaria vaccine by 2010?, Libby Levison
  • [e-drug] Antidepressants in USA to carry warning for young, Libby Levison
  • [e-drug] Access to Medicines in Under-served Markets: overview (2), Richard T. Mahoney
  • [e-drug] a malaria vaccine by 2010? (2), Bernhard Edgren
  • [e-drug] Rational Drug Management Course, natascha_petersen
  • [e-drug] Can we document experiences with PEPFAR please?, EPN Nairobi
  • [e-drug] after Vioxx, now Bextra?, E-drug
  • [e-drug] Two drug systems in the U.S., Sarah Sellers
  • [e-drug] after Vioxx, now Bextra? (2), Roger Klotz
  • [e-drug] Let the Pharmaceutical Industry Speak (3), Wasonga, John (KENYA/OPH)
  • [e-drug] Can we document experiences with PEPFAR please? (3), Francisco Rossi
  • [e-drug] Two drug systems in the U.S. (3), Sarah Sellers
  • [e-drug] Two drug systems in the U.S. (4), Parrish Richard
  • [e-drug] Two drug systems in the U.S. (5), Sarah Sellers
  • [e-drug] vioxx withdrawal - insider story, E-Drug
  • [e-drug] Electronic Listing of Registered Products?, Murtada Sesay
  • [e-drug] Electronic Listing of Registered Products? (2), Natalie Pieterse
  • [e-drug] Two drug systems in the U.S. (7), Parrish Richard
  • [e-drug] Defense Contractors Seek $7-Billion Drug Grant, Johanna Crane
  • [e-drug] Two drug systems in the U.S. (10), Sarah Sellers
  • [e-drug] Pharmaceutical Commodities Management Officer, Jacqui Patterson
  • [e-drug] APPROVe (VIOXX) trial publication?, Ruwan Prasad
  • [e-drug] Indian drug R&D has bright future, E-Drug
  • [e-drug] rofecoxib ban in India, clinicsindia
  • [e-drug] drug companies and regulators in the spotlight, E-Drug
  • [e-drug] brand vs generic simvastatin prices?, valeria . frighi
  • [e-drug] Essential drugs without essential staff (4), Timothy Mahlatsi
  • [e-drug] Before or after food? (2), Elizabeth Ominde-Ogaja
  • [e-drug] proposed WHO EML changes 2005, E-Drug
  • [e-drug] Drugs companies are defrauding healthcare systems? (2), Roger Klotz
  • [e-drug] Need for a protocol repository, Kent Johnson
  • [e-drug] MSF: TB is spiralling out of control, Sean Healy
  • [e-drug] 34rd edition of Martindale, E-Drug
  • [e-drug] MSF: TB is spiralling out of control (2), Wasonga, John (KENYA/OPH)
  • [e-drug] 34rd edition of Martindale (2), Moses Mwaniki
  • [e-drug] Australian Endocrinology Guidelines, Enid Meldrum
  • [e-drug] Cost/efficient procurement, Arnaud PECOURT
  • [e-drug] 34rd edition of Martindale (3), Serutoke, Mr. Joseph - ug
  • [e-drug] Martindale Online Access, JPS Kohli
  • [e-drug] RFI: quinine syrup, Betty Njau
  • [e-drug] The World's First TB Vaccine in Eighty Years, Leela McCullough
  • [e-drug] Malaria News: resistance, counterfeits, Leela McCullough
  • [e-drug] Cost of retaining essential staff?, Bonface Fundafunda
  • [e-drug] occupational risks of antineoplastic API production?, Sunil Singh
  • [e-drug] Pharmacy Education Symposium, Italy 2005, Rohan Elliott
  • [e-drug] Masters thesis on paediatric formulations (2), Satu Siiskonen
  • [e-drug] USA pays high prices for global AIDS drugs, E-Drug
  • [e-drug] Fair Access to Clinical Trials Act, E-Drug
  • [e-drug] Evidence based medicine for developing countries, E-Drug
  • [e-drug] Cost of Viral Load Test down by 60%, E-Drug

  • Mail converted by MHonArc 2.6.8